The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

AORT FINANCIAL STATEMENTS

Artivion Inc — balance sheet, income statement and cash flow trends

AORTArtivion Inc

🇺🇸 USA · NYSE · Healthcare · Medical Devices

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
0200 M400 M202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue471.5 M $Gross Profit296.1 M $ · 63%Operating Income18.8 M $ · 4%Pre-tax Income2.2 M $ · 0%Net Income to Owners-3.2 M $ · -1%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue471.5 M $+16.4%
Gross Profit296.1 M $+14.2%
Operating Income18.8 M $+7.1%
EBITDA57.4 M $+44.3%
Net Income to Owners-3.2 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0500 M1 B202120222023202420252026

Capital Structure

Q2 2026
Total Assets1.1 B
  • Equity445.6 M $42%
  • Current Liabilities106.9 M $10%
  • Long-term Liabilities519.4 M $48%

Key Figures

YoY change
Total Assets1.1 B $+27.9%
Total Liabilities626.3 M $+49.7%
Total Equity445.6 M $+6.1%
Cash & ST Investments77.3 M $+44.6%
Total Debt408 M $+54.7%
Net Debt330.7 M $+57.3%

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-25 M025 M50 M202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-100 M-50 M040 M $Operating-175 M $Investing159.3 M $Financing24.3 M $Net Change

Key Figures

YoY change
Operating Cash Flow40 M $+103.3%
Capital Expenditures50.9 M $+324.3%
Free Cash Flow-10.9 M $-242.3%
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on AORT

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.